CureVac Cash Flow Statement Analysis

Operating, investing, and financing activities in billions EUR

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for CureVac N.V. (CVAC) - Annual data in billions EUR
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income0.16-0.26-0.25-0.41-0.13
Depreciation & Amortization0.020.020.020.020.01
Stock Based Compensation0.000.010.010.010.01
Change in Working Capital-0.16-0.09-0.18-0.070.61
Change in Accounts Receivable0.010.010.02-0.020.02
Change in Inventory0.00-0.05-0.05-0.23-0.01
Change in Accounts Payable-0.14-0.03-0.100.180.62
Change in Other Working Capital-0.01-0.010.00-0.48-0.05
Other Operating Activities-0.01-0.010.00-0.480.01
Net Cash from Operating Activities0.10-0.27-0.29-0.730.52
Investing Activities
Capital Expenditures-0.02-0.06-0.09-0.13-0.04
Acquisitions0.000.000.000.000.00
Purchases of Investments0.000.000.000.000.00
Sales/Maturities of Investments0.000.00-0.010.00-0.01
Other Investing Activities0.000.000.000.000.00
Net Cash from Investing Activities-0.02-0.06-0.09-0.13-0.05
Financing Activities
Debt Repayment-0.01-0.010.00-0.030.00
Common Stock Issued0.000.240.070.400.87
Common Stock Repurchased0.000.000.00-0.030.00
Net Cash from Financing Activities-0.010.230.060.340.82
Summary
Effect of Forex Changes on Cash0.000.000.000.000.00
Net Change in Cash0.08-0.09-0.32-0.521.29
Cash at Beginning of Period0.400.500.811.320.00
Cash at End of Period0.480.400.500.810.00
Free Cash Flow0.08-0.32-0.38-0.860.49
Supplemental Disclosures
Interest Paid0.000.000.000.010.01
Income Taxes Paid0.000.000.000.000.00